Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
2
×
detroit blog main
detroit top stories
2
×
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle genetics
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aducanumab
affordable care act
aldeyra therapeutics
alex azar
allergan aesthetics
amgen
astrazeneca
What
bio
drug
roundup
week
2
×
acquisitions
aducanumab
alzheimer’s
amyloid
angst
bagged
biggest
billions
biogen
biogen’s
brammer
build
buy
ceo
company’s
daniel
debut
dyne’s
effects
failure
felt
gilead
lost
microbiome
moves
nash
news
openly
o’day
pipeline
ripple
sciences
scores
seagen
spoken
way
Language
unset
Current search:
week
×
deals
×
" detroit top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More